Clarke P. Anderson

Depletion of Glutathione by Buthionine Sulfoximine Is Cytotoxic for Human Neuroblastoma Cell Lines via Apoptosis

Clarke P. Anderson, Janice M. Tsai, William E. Meek et al. · Experimental Cell Research · 1999 · 108 citations

Life Sciences, Biochemistry, Oncology +10

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho et al. · Pediatric Blood & Cancer · 2016 · 95 citations · Full text

Medicine, Oncology, Pharmacology +14

Pilot study of intravenous melphalan combined with continuous infusion L-<i>S,R</i>-buthionine sulfoximine for children with recurrent neuroblastoma

Clarke P. Anderson, Katherine K. Matthay, John P. Perentesis et al. · Pediatric Blood & Cancer · 2015 · 36 citations

Medicine, Oncology, Pharmacology +13

Buthionine Sulfoximine and Myeloablative Concentrations of Melphalan Overcome Resistance in a Melphalan-Resistant Neuroblastoma Cell Line

Clarke P. Anderson, Robert C. Seeger, Noriko Satake et al. · ˜The œAmerican journal of pediatric hematology/oncology · 2001 · 35 citations

Medicine, Oncology, Pharmacology +14

Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium

Nancy D. Doolittle, Clarke P. Anderson, W. Archie Bleyer et al. · Neuro-Oncology · 2001 · 31 citations

Medicine, Oncology, Pharmacology +9